The ADDF offers funding to researchers in both nonprofit and for-profit organizations for drug discovery, clinical trials, and biomarker development. Visit our Research Priorities for specific information about our interests.

ADDF FUNDING PORTAL

LOG IN OR
CREATE ACCOUNT

The majority of funding is provided through four Core Requests for Proposals (RFPs). Letters of intent are accepted and reviewed on a rolling basis during four cycles each year, with corresponding deadlines for invited full proposals. Check back throughout the year for additional funding opportunities through our collaborations with non-profit, government, and industry partners.

Read our policies on application submissions and funding for Core RFPs.

CORE REQUESTS FOR PROPOSALS


Program to Accelerate Clinical Trials (PACT) RFP

This RFP funds early-stage clinical trials through phase 2 for novel drug candidates, proof-of-concept trials in patients for repurposed/repositioned drugs, and regulatory studies for IND/CTA preclinical packages and drug manufacturing for later stage trials.

 
 

Neuroimaging and CSF Biomarker Development RFP

This RFP supports the development and validation of neuroimaging and CSF biomarkers to enhance clinical trials for Alzheimer's disease, related dementias, and cognitive aging.

 
 

Prevention Beyond the Pipeline RFP

This RFP supports comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.

 
 

Drug Discovery RFP

This RFP supports programs advancing lead molecules to clinical candidate selection or building preclinical evidence in relevant animal models for repurposed/repositioned drugs.

 

 

OTHER REQUESTS FOR PROPOSALS


The Treat FTD Fund RFP

Supports clinical development of novel and repurposed drugs for FTD disorders through proof-of-concept and pilot proof-of-mechanism trials or phase 0/1 studies in healthy volunteers assessing pharmacodynamic outcomes. This program is in partnership with The Association for Frontotemporal Degeneration.

Deadlines

Letter of Intent: November 9, 2018
Full Proposal: February 15, 2019

 
 

Diagnostics Accelerator: Peripheral Biomarkers RFP

Seeks to support proof-of-principle and validation studies for peripheral biomarkers and novel diagnostic technologies for Alzheimer's disease and related dementias. Funding and committed project support by from industry experts is provided through a collaboration between the ADDF, Bill Gates, and other partners.

Deadlines

Passed

 

 

OTHER ADDF FUNDING OPPORTUNITIES


ADDF/NIH Funding

Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities.

 
 

Conference Funding

Supports scientific conferences that are relevant to our mission with grants up to $10,000. For more information, email grants@alzdiscovery.org with a brief summary of your conference

 


Stay Updated on Upcoming Deadlines and RFP Announcements

Sign up to receive news by email.